Research studies in the Open Payments record
139,921 studies have research funding reported against them. Being named on a study as a principal investigator is reported separately from being paid.
Studies
50 of 139,921- 24023 – ZEUS (510K) Method Comparison Adult: Arterial and Venous blood for PICO A and safePICO A No ClinicalTrials.gov identifier reported
- 24023 – ZEUS (510K) Method Comparison Adult: Arterial and Venous blood for PICO A and safePICO A No ClinicalTrials.gov identifier reported
- 24023 – ZEUS (510K) Method Comparison Adult: Arterial and Venous blood for PICO A and safePICO A No ClinicalTrials.gov identifier reported
- 24023 – ZEUS (510K) Method Comparison Adult: Arterial and Venous blood for PICO A and safePICO A No ClinicalTrials.gov identifier reported
- 24023 – ZEUS (510K) Method Comparison Adult: Arterial and Venous blood for PICO A and safePICO A No ClinicalTrials.gov identifier reported
- 24023 – ZEUS (510K) Method Comparison Adult: Arterial and Venous blood for PICO A and safePICO A No ClinicalTrials.gov identifier reported
- 24023 – ZEUS (510K) Method Comparison Adult: Arterial and Venous blood for PICO A and safePICO A No ClinicalTrials.gov identifier reported
- 24023 – ZEUS (510K) Method Comparison Adult: Arterial and Venous blood for PICO A and safePICO A No ClinicalTrials.gov identifier reported
- 24023 – ZEUS (510K) Method Comparison Adult: Arterial and Venous blood for PICO A and safePICO A No ClinicalTrials.gov identifier reported
- 24023 – ZEUS (510K) Method Comparison Adult: Arterial and Venous blood for PICO A and safePICO A No ClinicalTrials.gov identifier reported
- 24023 – ZEUS (510K) Method Comparison Adult: Arterial and Venous blood for PICO A and safePICO A No ClinicalTrials.gov identifier reported
- 24023 – ZEUS (510K) Method Comparison Adult: Arterial and Venous blood for PICO A and safePICO A No ClinicalTrials.gov identifier reported
- 24023 – ZEUS (510K) Method Comparison Adult: Arterial and Venous blood for PICO A and safePICO A No ClinicalTrials.gov identifier reported
- 24023 – ZEUS (510K) Method Comparison Adult: Arterial and Venous blood for PICO A and safePICO A No ClinicalTrials.gov identifier reported
- 24023 – ZEUS (510K) Method Comparison Adult: Arterial and Venous blood for PICO A and safePICO A No ClinicalTrials.gov identifier reported
- 24023 – ZEUS (510K) Method Comparison Adult: Arterial and Venous blood for PICO A and safePICO A No ClinicalTrials.gov identifier reported
- 24023 – ZEUS (510K) Method Comparison Adult: Arterial and Venous blood for PICO A and safePICO A No ClinicalTrials.gov identifier reported
- 24023 – ZEUS (510K) Method Comparison Adult: Arterial and Venous blood for PICO A and safePICO A No ClinicalTrials.gov identifier reported
- 24023 – ZEUS (510K) Method Comparison Adult: Arterial and Venous blood for PICO A and safePICO A No ClinicalTrials.gov identifier reported
- 24023 – ZEUS (510K) Method Comparison Adult: Arterial and Venous blood for PICO A and safePICO A No ClinicalTrials.gov identifier reported
- 24023 – ZEUS (510K) Method Comparison Adult: Arterial and Venous blood for PICO A and safePICO A No ClinicalTrials.gov identifier reported
- 24023 – ZEUS (510K) Method Comparison Adult: Arterial and Venous blood for PICO A and safePICO A No ClinicalTrials.gov identifier reported
- 24023 – ZEUS (510K) Method Comparison Adult: Arterial and Venous blood for PICO A and safePICO A No ClinicalTrials.gov identifier reported
- 24023 – ZEUS (510K) Method Comparison Adult: Arterial and Venous blood for PICO A and safePICO A No ClinicalTrials.gov identifier reported
- 24023 – ZEUS (510K) Method Comparison Adult: Arterial and Venous blood for PICO A and safePICO A No ClinicalTrials.gov identifier reported
- 24023 – ZEUS (510K) Method Comparison Adult: Arterial and Venous blood for PICO A and safePICO A No ClinicalTrials.gov identifier reported
- 24023 – ZEUS (510K) Method Comparison Adult: Arterial and Venous blood for PICO A and safePICO A No ClinicalTrials.gov identifier reported
- 24023 – ZEUS (510K) Method Comparison Adult: Arterial and Venous blood for PICO A and safePICO A No ClinicalTrials.gov identifier reported
- 24023 – ZEUS (510K) Method Comparison Adult: Arterial and Venous blood for PICO A and safePICO A No ClinicalTrials.gov identifier reported
- 24023 – ZEUS (510K) Method Comparison Adult: Arterial and Venous blood for PICO A and safePICO A No ClinicalTrials.gov identifier reported
- 24023 – ZEUS (510K) Method Comparison Adult: Arterial and Venous blood for PICO A and safePICO A No ClinicalTrials.gov identifier reported
- 24023 – ZEUS (510K) Method Comparison Adult: Arterial and Venous blood for PICO A and safePICO A No ClinicalTrials.gov identifier reported
- 24023 – ZEUS (510K) Method Comparison Adult: Arterial and Venous blood for PICO A and safePICO A No ClinicalTrials.gov identifier reported
- 24023 – ZEUS (510K) Method Comparison Adult: Arterial and Venous blood for PICO A and safePICO A No ClinicalTrials.gov identifier reported
- 24023 – ZEUS (510K) Method Comparison Adult: Arterial and Venous blood for PICO A and safePICO A No ClinicalTrials.gov identifier reported
- 240865 No ClinicalTrials.gov identifier reported
- 246-13651-301 No ClinicalTrials.gov identifier reported
- 246-13651-302 No ClinicalTrials.gov identifier reported
- 248C1: Xpress CTNG No ClinicalTrials.gov identifier reported
- 2498 Ltfu - Phase I/II Study of Adoptive Immunotherapy With Virus Specific Cd8+ T Cells That Have Been Transduced+Gz1173 to Express A Wt1-Specific T Cell Receptor for Patients With High Risk Or Relapsed Aml, MDS, Or CM No ClinicalTrials.gov identifier reported
- 24G-NIH - Simultaneous Multi-A No ClinicalTrials.gov identifier reported
- 24h IOP variation before and after implantation of the Hydrus Microstent using remote home tonometry No ClinicalTrials.gov identifier reported
- 24-Hour Ambulatory Blood Pressure Monitoring Study in Hypogonadal Men Receiving Testosterone Replacement Therapy NCT04274894
- 24-hour Ambulatory Blood Pressure Monitoring Study in Hypogonadal Men Treated with Natesto Nasal Testosterone Gel No ClinicalTrials.gov identifier reported
- 24-Mar No ClinicalTrials.gov identifier reported
- 24 Multi-site Urticaria Registry Study No ClinicalTrials.gov identifier reported
- 24-Oct No ClinicalTrials.gov identifier reported
- 24 Weeks Double-blind Randomized Placebo-controlled Trial to Evaluate Efficacy, PK, Safety of LOU064 in Adolescents (12 - <18) With CSU and Inadequate Response to H1-antihistamine Followed by Optional 3 Years Open-label Extension and an Optional 3 Years S No ClinicalTrials.gov identifier reported
- 25-007009 Impact of 1 mg osilodrostat therapy on mild autonomous cortisol secretion (MACS) No ClinicalTrials.gov identifier reported
- 251 Roll-Over Study-Enrolled Phase 1/2, Open-Label Study of Rux for patients with PMF and Post-PV/ET MF No ClinicalTrials.gov identifier reported